ATE246506T1 - Darmlösliche sprudelnde zusammensetzungen - Google Patents

Darmlösliche sprudelnde zusammensetzungen

Info

Publication number: ATE246506T1
Authority: AT; Austria
Prior art keywords: glycyrrhizin; preparation; present; effective compositions; soluble effective
Prior art date: 1998-03-11

Application number

AT99939145T

Other languages

English (en)

Inventor

Hashime Kanazawa

Kenji Shimizu

Kazuhiro Sasaki

Tetsuya Sugimoto

Original Assignee

Grelan Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-11

Filing date

1999-03-10

Publication date

2003-08-15

1999-03-10 Application filed by Grelan Pharmaceutical Co filed Critical Grelan Pharmaceutical Co

2003-08-15 Application granted granted Critical

2003-08-15 Publication of ATE246506T1 publication Critical patent/ATE246506T1/de

Links

230000000968 intestinal effect Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
238000002360 preparation method Methods 0.000 abstract 4
239000004378 Glycyrrhizin Substances 0.000 abstract 3
LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 abstract 3
229960004949 glycyrrhizic acid Drugs 0.000 abstract 3
UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 abstract 3
235000019410 glycyrrhizin Nutrition 0.000 abstract 3
LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 3
238000010521 absorption reaction Methods 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
239000003623 enhancer Substances 0.000 abstract 1
150000004667 medium chain fatty acids Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Compounds Of Unknown Constitution (AREA)
Curing Cements, Concrete, And Artificial Stone (AREA)

AT99939145T 1998-03-11 1999-03-10 Darmlösliche sprudelnde zusammensetzungen ATE246506T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP7648798		1998-03-11
PCT/JP1999/001157 WO1999045934A1 (fr)	1998-03-11	1999-03-10	Preparations entero-solubles effervescentes

Publications (1)

Publication Number	Publication Date
ATE246506T1 true ATE246506T1 (de)	2003-08-15

Family

ID=13606583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99939145T ATE246506T1 (de)	1998-03-11	1999-03-10	Darmlösliche sprudelnde zusammensetzungen

Country Status (9)

Country	Link
US (1)	US6326360B1 (de)
EP (1)	EP1062952B1 (de)
JP (1)	JP4372347B2 (de)
KR (1)	KR20010041696A (de)
CN (1)	CN1160079C (de)
AT (1)	ATE246506T1 (de)
DE (1)	DE69910183T2 (de)
DK (1)	DK1062952T3 (de)
WO (1)	WO1999045934A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030118645A1 (en) *	1998-04-29	2003-06-26	Pather S. Indiran	Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en)	1998-03-27	2005-12-13	Cima Labs Inc.	Sublingual buccal effervescent
US20030091629A1 (en)	1998-03-27	2003-05-15	Cima Labs Inc.	Sublingual buccal effervescent
US6350470B1 (en) *	1998-04-29	2002-02-26	Cima Labs Inc.	Effervescent drug delivery system for oral administration
US20070148228A1 (en) *	1999-02-22	2007-06-28	Merrion Research I Limited	Solid oral dosage form containing an enhancer
US8119159B2 (en)	1999-02-22	2012-02-21	Merrion Research Iii Limited	Solid oral dosage form containing an enhancer
US7658938B2 (en) *	1999-02-22	2010-02-09	Merrion Reasearch III Limited	Solid oral dosage form containing an enhancer
US6414016B1 (en)	2000-09-05	2002-07-02	Sucampo, A.G.	Anti-constipation composition
JP5026655B2 (ja) *	2001-04-18	2012-09-12	プロメティック、バイオサイエンシーズ、インコーポレーテッド	好中球の生存及び活性化因子としての中鎖脂肪酸、グリセリド及び類似体
EP1392272B1 (de) *	2001-05-11	2014-08-06	Merrion Research III Limited	Permeationsverbesserer
CA2446622C (en) *	2001-05-11	2012-08-14	Elan Corporation, Plc	Isostearic acid salts as permeation enhancers
US20030068356A1 (en) *	2001-07-10	2003-04-10	Pather S. Indiran	Sequential drug delivery systems
JP3980851B2 (ja) *	2001-08-30	2007-09-26	有限会社ゴトーコーポレーション	固型製剤、その製造方法、及び食品
GB0217056D0 (en) *	2002-07-23	2002-08-28	Ass Octel	Use
UA76638C2 (en)	2002-08-02	2006-08-15	Oleh Illich Epshtein	Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon
UA76639C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій
UA76641C2 (uk) *	2002-08-02	2006-08-15	Олєг Ільіч Епштєйн	Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози
ATE419846T1 (de)	2003-02-07	2009-01-15	Prometic Biosciences Inc	Fettsäuren mittlerer kettenlänge, glyceride und analoga als stimulatoren der erythropoiese
CN102078310B (zh) *	2003-12-31	2013-01-23	奇马实验室公司	大体线性的泡腾口服芬太尼剂型和施用方法
US7862833B2 (en)	2003-12-31	2011-01-04	Cima Labs, Inc.	Effervescent oral opiate dosage forms and methods of administering opiates
WO2005065317A2 (en)	2003-12-31	2005-07-21	Cima Labs Inc.	Effervescent oral fentanyl dosage form
US20070219131A1 (en) *	2004-04-15	2007-09-20	Ben-Sasson Shmuel A	Compositions capable of facilitating penetration across a biological barrier
CA2563533C (en) *	2004-04-15	2013-10-01	Shmuel A. Ben-Sasson	Compositions capable of facilitating penetration across a biological barrier
US9592324B2 (en)	2006-11-06	2017-03-14	Atrium Medical Corporation	Tissue separating device with reinforced support for anchoring mechanisms
US8312836B2 (en)	2004-09-28	2012-11-20	Atrium Medical Corporation	Method and apparatus for application of a fresh coating on a medical device
EP1811935B1 (de)	2004-09-28	2016-03-30	Atrium Medical Corporation	Wärmegehärtetes gel und herstellungsverfahren
US20060067977A1 (en)	2004-09-28	2006-03-30	Atrium Medical Corporation	Pre-dried drug delivery coating for use with a stent
US9000040B2 (en)	2004-09-28	2015-04-07	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US9012506B2 (en)	2004-09-28	2015-04-21	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US8367099B2 (en)	2004-09-28	2013-02-05	Atrium Medical Corporation	Perforated fatty acid films
US9801982B2 (en)	2004-09-28	2017-10-31	Atrium Medical Corporation	Implantable barrier device
US9278161B2 (en)	2005-09-28	2016-03-08	Atrium Medical Corporation	Tissue-separating fatty acid adhesion barrier
US9427423B2 (en)	2009-03-10	2016-08-30	Atrium Medical Corporation	Fatty-acid based particles
AU2006304590A1 (en)	2005-10-15	2007-04-26	Atrium Medical Corporation	Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
CN100391466C (zh) *	2006-02-17	2008-06-04	武汉大学	甘草酸铵盐在制备治疗炎症性肠病药物中的应用
RU2309732C1 (ru) *	2006-03-13	2007-11-10	Олег Ильич Эпштейн	Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата
BRPI0710503A2 (pt)	2006-04-07	2011-08-16	Merrion Res Iii Ltd	uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
BRPI0712540A2 (pt) *	2006-06-06	2012-10-16	Oleg Iliich Epshtein	agente medicinal para tratar adiposidade, diabetes, e doenças associadas com intoleráncia a glicose
JP2009539862A (ja) *	2006-06-09	2009-11-19	メリオンリサーチＩｉｉリミテッド	強化剤を含む固体経口投与剤形
US9492596B2 (en)	2006-11-06	2016-11-15	Atrium Medical Corporation	Barrier layer with underlying medical device and one or more reinforcing support structures
RU2517135C2 (ru)	2008-05-07	2014-05-27	Меррион Рисерч Iii Лимитед	Композиции пептидов и способы их получения
KR101814186B1 (ko)	2008-09-17	2018-03-14	키아스마 인코포레이티드	약제학적 조성물 및 연관된 투여방법
US20110038910A1 (en)	2009-08-11	2011-02-17	Atrium Medical Corporation	Anti-infective antimicrobial-containing biomaterials
JPWO2011118453A1 (ja)	2010-03-23	2013-07-04	リンテック株式会社	固形製剤
US9089484B2 (en)	2010-03-26	2015-07-28	Merrion Research Iii Limited	Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
PH12013500107A1 (en)	2010-07-15	2013-03-11	Oleg Iliich Epshtein	A method of increasing the effect of an activated-potentiated form of an antibody
US10322213B2 (en)	2010-07-16	2019-06-18	Atrium Medical Corporation	Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
EA029199B1 (ru)	2010-07-21	2018-02-28	Олег Ильич Эпштейн	Комбинированная фармацевтическая композиция для лечения синдрома дефицита внимания и гиперактивности и способы лечения синдрома дефицита внимания и гиперактивности
CA2813606C (en)	2010-10-07	2019-01-22	Sarkis K. Mazmanian	Probiotic therapies for autism
KR20140026354A (ko)	2011-01-07	2014-03-05	메리온 리서치 Ⅲ 리미티드	경구 투여용 철의 제약 조성물
CN102499925B (zh) *	2011-10-21	2015-11-11	上海中医药大学	一种中性粒细胞弹性蛋白酶抑制剂
US9867880B2 (en)	2012-06-13	2018-01-16	Atrium Medical Corporation	Cured oil-hydrogel biomaterial compositions for controlled drug delivery
WO2014118997A1 (ja) *	2013-01-30	2014-08-07	宏輝システムズ株式会社	新規多価アルコール基剤ソフトカプセル製剤
CN103330684A (zh) *	2013-07-01	2013-10-02	杭州市西溪医院	甘草酸二铵脂质复合物泡腾颗粒的制备方法
JP2016029034A (ja) *	2014-07-18	2016-03-03	ナノメガメディカルコーポレイションＮａｎｏｍｅｇａＭｅｄｉｃａｌＣｏｒｐｏｒａｔｉｏｎ	医薬組成物
JP7211704B2 (ja)	2015-01-29	2023-01-24	ノヴォノルディスクアー／エス	Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
WO2016126830A1 (en)	2015-02-03	2016-08-11	Chiasma Inc.	Method of treating diseases
US11141457B1 (en)	2020-12-28	2021-10-12	Amryt Endo, Inc.	Oral octreotide therapy and contraceptive methods
AU2024359017A1 (en) *	2023-10-13	2026-03-05	Enterotarget Aps	Capsule for delivery of a carrier system with a locally acting cargo to the intestines of a mammal

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5157813A (en)	1974-11-14	1976-05-20	Sankyo Co	Ll dooba mataha sonojudotaiseizaino seiho
JPS6032714A (ja) *	1983-08-01	1985-02-19	Teijin Ltd	鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
US4687662A (en) *	1985-08-30	1987-08-18	Warner-Lambert Company	Therapeutic effervescent composition
JPH03255037A (ja) *	1990-03-02	1991-11-13	Santen Pharmaceut Co Ltd	グリチルリチン製剤
JPH06192107A (ja)	1992-12-25	1994-07-12	Sanwa Kagaku Kenkyusho Co Ltd	グリチルリチン経口剤
JP3603327B2 (ja) *	1994-04-12	2004-12-22	大日本インキ化学工業株式会社	糖尿病治療剤
US5567439A (en) *	1994-06-14	1996-10-22	Fuisz Technologies Ltd.	Delivery of controlled-release systems(s)
US5498425A (en) *	1995-03-17	1996-03-12	Block Drug Company, Inc.	Phosphosoda buffered saline laxative

1999
- 1999-03-10 US US09/623,706 patent/US6326360B1/en not_active Expired - Fee Related
- 1999-03-10 JP JP2000535349A patent/JP4372347B2/ja not_active Expired - Fee Related
- 1999-03-10 DE DE69910183T patent/DE69910183T2/de not_active Expired - Fee Related
- 1999-03-10 WO PCT/JP1999/001157 patent/WO1999045934A1/ja not_active Ceased
- 1999-03-10 KR KR1020007009915A patent/KR20010041696A/ko not_active Abandoned
- 1999-03-10 DK DK99939145T patent/DK1062952T3/da active
- 1999-03-10 CN CNB998038903A patent/CN1160079C/zh not_active Expired - Fee Related
- 1999-03-10 AT AT99939145T patent/ATE246506T1/de not_active IP Right Cessation
- 1999-03-10 EP EP99939145A patent/EP1062952B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1999045934A1 (fr)	1999-09-16
KR20010041696A (ko)	2001-05-25
EP1062952A1 (de)	2000-12-27
CN1292703A (zh)	2001-04-25
EP1062952B1 (de)	2003-08-06
DE69910183D1 (de)	2003-09-11
EP1062952A4 (de)	2002-06-12
DK1062952T3 (da)	2003-11-24
JP4372347B2 (ja)	2009-11-25
US6326360B1 (en)	2001-12-04
DE69910183T2 (de)	2004-06-03
CN1160079C (zh)	2004-08-04

Legal Events

Date	Code	Title	Description
2004-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE246506T1 (de)	2003-08-15	Darmlösliche sprudelnde zusammensetzungen
EE05450B1 (et)	2011-08-15	4-jodofenlaminobenshdroksaamhapete oksgeenitud estrid, nende kristallvormid ja farmatseutilised kompositsioonid ning kasutamine
DE69534676D1 (de)	2006-01-12	Orale Verabreichung von chemisch modifizierten Proteinen
HUP0000450A3 (en)	2001-02-28	The use of 7-(2-oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-quinolone carboxylic acid and naphthyridon carboxylic acid derivatives for the preparation of pharmaceutical compositions treating helicobacter pylori infections and associated gastroduodenal diseases
IS4067A (is)	1994-02-27	PEG-Interferonafleiður, aðferð til framleiðslu þeirra, og notkunar sem lyfja
BR9710509A (pt)	1999-08-17	FÄrmula de vacina polinucleot¡dica contra as patologias caninas especialmente as patologias respiratÄrias e digestivas
EP1247456A3 (de)	2003-12-10	Wohlschmeckende pharmazeutische Zusammensetzung für Haustiere
MY117606A (en)	2004-07-31	Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
HUP0203716A3 (en)	2004-05-28	Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect and pharmaceutical compositions containing them
EP1219630A4 (de)	2004-05-26	Immunverstärkende verbindungen
DE60213283D1 (de)	2006-08-31	Pharmazeutische zusammensetzung enthaltend magermilchpulver
DE69837142D1 (de)	2007-04-05	Herstellung einer fumarsäureenthaltenden lebensmittelsäurezusammensetzung
CA2252399A1 (en)	1997-11-06	Composition for demonstrating the presence of ammonia in exhaled air
BR9710377A (pt)	1999-08-17	Gr-nulos de derivados de hexahidropirazina administr veis por via oral
ATE145788T1 (de)	1996-12-15	Herbizide zusammensetzungen
PT1312355E (pt)	2003-10-31	Composicoes farmaceuticas nao-efervescentes soluveis em agua compreendendo drogas anti-inflamatorias nao-esteroides
CA2374471A1 (en)	2000-12-07	Therapeutically and/or nutritionally enhanced derivatives of active ingredients and orally administrable compositions containing same
GB9827095D0 (en)	1999-02-03	Administration of benefical substances to ruminant animals
CA2383755A1 (en)	2001-03-15	Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
DE69729729D1 (de)	2004-08-05	Arzneimittel zur anwendung im mund
RU97117569A (ru)	1999-08-20	Гастроветин
RU97115183A (ru)	1999-06-27	Средство для лечения диареи у детей с хроническими заболеваниями тонкой кишки
EP1595879A3 (de)	2010-01-27	Alkoxy substituierte Benzimidazolverbindungen , diese enthaltende Arzneimittel und ihre Vervendung
RU2001113135A (ru)	2003-03-10	Растворимая шипучая композиция "эккосол" с экстрактом корня солодки, обладающая иммуностимулирующим, антиаллергическим, противовоспалительным, противоязвенным, антибактериальным и отхаркивающим действием
RU99108232A (ru)	2001-03-10	Композиция ингредиентов для безалкогольного витаминизированного тонизирующего напитка "ая-ганга"